AR034277A1 - Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion - Google Patents
Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccionInfo
- Publication number
- AR034277A1 AR034277A1 ARP010105391A ARP010105391A AR034277A1 AR 034277 A1 AR034277 A1 AR 034277A1 AR P010105391 A ARP010105391 A AR P010105391A AR P010105391 A ARP010105391 A AR P010105391A AR 034277 A1 AR034277 A1 AR 034277A1
- Authority
- AR
- Argentina
- Prior art keywords
- pantoprazol
- preparation
- injection
- liophilized
- pantoprazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Proceso para la producción de una preparación liofilizada que comprende 5-difluorometoxi-2-[(3,4-dimetoxi-2-pirimidinil)metilsulfinil]-1-H-bencimidazol (pantoprazol), una sal del mismo, un solvato de pantoprazol o una sal del mismo, que comprende liofilizar una solución acuosa de pantroprazol, una sal del mismo, un solvato de pantoprazol o una sal del mismo, ácido etilenodiaminotetraacético y/o una sal de adecuada del mismo, e hidróxido de sodio y/o carbonato de sodio.Se describe una preparación liofilizada de pantoprazol, así como una inyección obtenible por reconstitución de la preparación liofilizada de pantoprazol en un disolvente adecuado y un kit para inyección.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00125569 | 2000-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034277A1 true AR034277A1 (es) | 2004-02-18 |
Family
ID=8170452
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010105391A AR034277A1 (es) | 2000-11-22 | 2001-11-19 | Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion |
| ARP130102967A AR092374A2 (es) | 2000-11-22 | 2013-08-21 | Preparacion liofilizada de 5-difluorometoxi-2-[(3,4-dimetoxi-2-piridinil)metilsulfinil]-1h-bencimidazol (pantoprazol) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130102967A AR092374A2 (es) | 2000-11-22 | 2013-08-21 | Preparacion liofilizada de 5-difluorometoxi-2-[(3,4-dimetoxi-2-piridinil)metilsulfinil]-1h-bencimidazol (pantoprazol) |
Country Status (40)
| Country | Link |
|---|---|
| US (3) | US6780881B2 (es) |
| EP (2) | EP1762249A3 (es) |
| JP (1) | JP4886158B2 (es) |
| KR (2) | KR100910606B1 (es) |
| CN (1) | CN1250292C (es) |
| AR (2) | AR034277A1 (es) |
| AT (1) | ATE381946T1 (es) |
| AU (2) | AU1604202A (es) |
| BG (1) | BG66329B1 (es) |
| BR (1) | BRPI0115483B8 (es) |
| CA (2) | CA2428870C (es) |
| CY (1) | CY1107896T1 (es) |
| CZ (1) | CZ304348B6 (es) |
| DE (1) | DE60132108T2 (es) |
| DK (1) | DK1339430T3 (es) |
| EA (1) | EA007602B1 (es) |
| EC (1) | ECSP034613A (es) |
| EE (1) | EE05236B1 (es) |
| ES (1) | ES2298295T3 (es) |
| GE (1) | GEP20053461B (es) |
| HK (1) | HK1060848A1 (es) |
| HR (1) | HRP20030410B1 (es) |
| HU (1) | HUP0303278A3 (es) |
| IL (2) | IL155601A0 (es) |
| IS (1) | IS2971B (es) |
| ME (1) | ME00556B (es) |
| MX (1) | MXPA03004548A (es) |
| MY (1) | MY137726A (es) |
| NO (1) | NO332937B1 (es) |
| NZ (1) | NZ525911A (es) |
| PE (1) | PE20020582A1 (es) |
| PL (1) | PL201188B1 (es) |
| PT (1) | PT1339430E (es) |
| RS (1) | RS52024B (es) |
| SI (1) | SI1339430T1 (es) |
| SK (1) | SK287993B6 (es) |
| TW (1) | TWI284041B (es) |
| UA (1) | UA80961C2 (es) |
| WO (1) | WO2002041919A1 (es) |
| ZA (1) | ZA200303593B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY137726A (en) * | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
| US20050287231A1 (en) * | 2002-06-21 | 2005-12-29 | Nussen Kenneth H | Method and apparatus for oral hygiene products with green tea extract |
| EP1562546A1 (en) * | 2002-10-25 | 2005-08-17 | Pfizer Products Inc. | Depot formulations of arylheterocyclic active agents in the form of a suspension |
| WO2004099183A1 (en) * | 2003-05-06 | 2004-11-18 | Hetero Drugs Limited | Novel polymorphs of pantoprazole sodium |
| CL2004000983A1 (es) * | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
| US20050004172A1 (en) * | 2003-05-19 | 2005-01-06 | Pliva-Istrazivacki Institut D.O.O. | Solid state forms of 5-(difluoro-methoxy)-2-((3,4-dimethoxy-2-pyridinyl)-methyl) sulfinyl]-1H-benzimidazole sodium aquo complexes |
| AR045258A1 (es) | 2003-08-21 | 2005-10-19 | Altana Pharma Ag | Un producto farmaceutico para inyeccion |
| WO2005070426A1 (en) * | 2004-01-27 | 2005-08-04 | Altana Pharma Ag | Freeze-dried (-)-pantoprazole preparation and (-)-pantoprazole injection |
| DE102004007854A1 (de) * | 2004-02-17 | 2005-09-01 | Hexal Ag | Stabile, wässrige Formulierung für Benzimidazole |
| US20060085924A1 (en) * | 2004-10-13 | 2006-04-27 | Gaelle Brun | Coloring composition comprising at least one pigment and at least one electrophilic cyanoacrylate monomer |
| CN1293879C (zh) * | 2005-01-20 | 2007-01-10 | 杭州华东医药集团生物工程研究所有限公司 | 泮托拉唑钠冻干粉针剂及其制备方法 |
| AU2006299424A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
| AR061155A1 (es) * | 2006-06-01 | 2008-08-06 | Combino Pharm Sl | Preparaciones liofilizadas de pantoprazol sodico para inyeccion |
| SI2049142T2 (sl) | 2006-07-26 | 2016-04-29 | Sandoz Ag | Formulacije kaspofungina |
| US7979200B2 (en) * | 2006-11-20 | 2011-07-12 | Lockheed Martin Corporation | Managing an air-ground communications network with air traffic control information |
| EP2106788A1 (en) * | 2008-04-04 | 2009-10-07 | Ipsen Pharma | Liquid and freeze dried formulations |
| CN101744777B (zh) * | 2009-12-30 | 2012-09-26 | 北京四环科宝制药有限公司 | 奥美拉唑钠冻干粉针剂及制备方法和检测方法 |
| CN101961309B (zh) * | 2010-09-15 | 2012-06-27 | 河南辅仁怀庆堂制药有限公司 | 注射用泮托拉唑钠配制工艺 |
| CN102000034B (zh) * | 2010-10-13 | 2011-12-21 | 江苏奥赛康药业股份有限公司 | 一种供注射用的s-泮托拉唑钠组合物及其制备方法 |
| CN102225063B (zh) * | 2011-05-10 | 2012-10-10 | 江苏奥赛康药业股份有限公司 | 一种供注射用的泮托拉唑钠组合物 |
| TR201108946A2 (tr) * | 2011-09-12 | 2012-04-24 | World Medicine İlaç Sanayi̇ Ve Ti̇caret Li̇mi̇ted Şi̇rketi̇ | Dondurularak kurutulmuş atp, vitamin b kompleksi preparatı ve enjeksiyonu. |
| CN104582687A (zh) * | 2012-06-27 | 2015-04-29 | 武田药品工业株式会社 | 用盐稳定的胺和有机酸的液体制剂 |
| CN104000786A (zh) * | 2013-02-25 | 2014-08-27 | 杭州赛利药物研究所有限公司 | 泮托拉唑钠冻干制剂及其制备方法 |
| CN104414979A (zh) * | 2013-08-21 | 2015-03-18 | 哈药集团三精制药股份有限公司 | 一种泮托拉唑钠冻干粉针剂及其制备方法 |
| CN104019635B (zh) * | 2014-06-19 | 2015-05-27 | 上海慈瑞医药科技有限公司 | 一种兰索拉唑原料药化合物及其干燥工艺 |
| CN104055791A (zh) * | 2014-07-10 | 2014-09-24 | 北京人福军威医药技术开发有限公司 | 西地碘治疗眼角结膜炎的用途 |
| CN104055792A (zh) * | 2014-07-10 | 2014-09-24 | 北京人福军威医药技术开发有限公司 | 西地碘治疗中耳炎的用途 |
| BE1021311B1 (nl) * | 2014-07-31 | 2015-10-28 | Neogen N.V. | Werkwijze voor het maken van een poedervormige protonpompremmer samenstelling, genoemde samenstelling en gebruik |
| EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| CN111643460A (zh) * | 2020-06-30 | 2020-09-11 | 武汉九州钰民医药科技有限公司 | 泮托拉唑钠冻干制剂及其制备方法、由其制得的注射制剂 |
| CN112274481A (zh) * | 2020-10-27 | 2021-01-29 | 海南卫康制药(潜山)有限公司 | 一种注射用泮托拉唑钠组合物及其制备方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8301182D0 (sv) | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
| IL75400A (en) | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
| US5223515A (en) | 1988-08-18 | 1993-06-29 | Takeda Chemical Industries, Ltd. | Injectable solution containing a pyridyl methylsulfinylbenzimidazole |
| DK399389A (da) | 1988-08-18 | 1990-02-19 | Takeda Chemical Industries Ltd | Injicerbare oploesninger |
| DE4035455A1 (de) | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
| DE69305642T2 (de) | 1992-07-28 | 1997-02-27 | Astra Ab, Soedertaelje | Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten |
| WO1994024867A1 (en) | 1993-04-27 | 1994-11-10 | Sepracor, Inc. | Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
| DE4324014C2 (de) * | 1993-07-17 | 1995-06-08 | Byk Gulden Lomberg Chem Fab | Verfahren zur Herstellung einer in Wasser rekonstituierbaren Zubereitung |
| TW280770B (es) | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| HU224987B1 (en) | 1995-11-03 | 2006-05-29 | Sanofi Aventis | Stable freeze-dried pharmaceutical formulation |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| EP1039905B1 (en) | 1997-10-14 | 2006-07-05 | Eisai Co., Ltd. | Pharmaceutical formulation comprising glycine as a stabilizer |
| DE19843413C1 (de) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
| WO2000026185A2 (en) | 1998-10-30 | 2000-05-11 | The Curators Of The University Of Missouri | Omeprazole solution and method of using same |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| CN1235018A (zh) * | 1999-04-22 | 1999-11-17 | 沈阳东宇药业有限公司 | 泮托拉唑钠冻干粉针剂及制备方法 |
| SE9903831D0 (sv) | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
| WO2002015908A1 (fr) * | 2000-08-18 | 2002-02-28 | Takeda Chemical Industries, Ltd. | Injections |
| MY137726A (en) * | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
| AR045258A1 (es) | 2003-08-21 | 2005-10-19 | Altana Pharma Ag | Un producto farmaceutico para inyeccion |
-
2001
- 2001-10-19 MY MYPI20014865A patent/MY137726A/en unknown
- 2001-11-06 TW TW090127545A patent/TWI284041B/zh not_active IP Right Cessation
- 2001-11-17 EP EP06123558.6A patent/EP1762249A3/en not_active Ceased
- 2001-11-17 CA CA002428870A patent/CA2428870C/en not_active Expired - Lifetime
- 2001-11-17 WO PCT/EP2001/013296 patent/WO2002041919A1/en active IP Right Grant
- 2001-11-17 AT AT01997314T patent/ATE381946T1/de active
- 2001-11-17 RS YU37703A patent/RS52024B/sr unknown
- 2001-11-17 UA UA20040705223A patent/UA80961C2/uk unknown
- 2001-11-17 ME MEP-2008-696A patent/ME00556B/me unknown
- 2001-11-17 CN CNB01819379XA patent/CN1250292C/zh not_active Expired - Lifetime
- 2001-11-17 BR BRPI0115483A patent/BRPI0115483B8/pt not_active IP Right Cessation
- 2001-11-17 PL PL361118A patent/PL201188B1/pl unknown
- 2001-11-17 GE GE5180A patent/GEP20053461B/en unknown
- 2001-11-17 KR KR1020037006675A patent/KR100910606B1/ko active IP Right Grant
- 2001-11-17 AU AU1604202A patent/AU1604202A/xx active Pending
- 2001-11-17 SK SK606-2003A patent/SK287993B6/sk not_active IP Right Cessation
- 2001-11-17 KR KR1020077027736A patent/KR100910607B1/ko active IP Right Grant
- 2001-11-17 EP EP01997314A patent/EP1339430B1/en not_active Revoked
- 2001-11-17 CA CA002541946A patent/CA2541946A1/en not_active Abandoned
- 2001-11-17 PT PT01997314T patent/PT1339430E/pt unknown
- 2001-11-17 SI SI200130816T patent/SI1339430T1/sl unknown
- 2001-11-17 DK DK01997314T patent/DK1339430T3/da active
- 2001-11-17 MX MXPA03004548A patent/MXPA03004548A/es active IP Right Grant
- 2001-11-17 JP JP2002544096A patent/JP4886158B2/ja not_active Expired - Fee Related
- 2001-11-17 HU HU0303278A patent/HUP0303278A3/hu unknown
- 2001-11-17 IL IL15560101A patent/IL155601A0/xx unknown
- 2001-11-17 NZ NZ525911A patent/NZ525911A/en not_active IP Right Cessation
- 2001-11-17 DE DE60132108T patent/DE60132108T2/de not_active Expired - Lifetime
- 2001-11-17 EE EEP200300182A patent/EE05236B1/xx not_active IP Right Cessation
- 2001-11-17 ES ES01997314T patent/ES2298295T3/es not_active Expired - Lifetime
- 2001-11-17 AU AU2002216042A patent/AU2002216042B2/en not_active Expired
- 2001-11-17 EA EA200300501A patent/EA007602B1/ru not_active IP Right Cessation
- 2001-11-17 CZ CZ2003-1416A patent/CZ304348B6/cs not_active IP Right Cessation
- 2001-11-19 PE PE2001001153A patent/PE20020582A1/es active IP Right Grant
- 2001-11-19 AR ARP010105391A patent/AR034277A1/es not_active Application Discontinuation
-
2002
- 2002-07-15 US US10/195,062 patent/US6780881B2/en not_active Expired - Lifetime
-
2003
- 2003-04-28 IL IL155601A patent/IL155601A/en active IP Right Grant
- 2003-05-09 ZA ZA200303593A patent/ZA200303593B/en unknown
- 2003-05-19 EC EC2003004613A patent/ECSP034613A/es unknown
- 2003-05-19 IS IS6820A patent/IS2971B/is unknown
- 2003-05-20 BG BG107828A patent/BG66329B1/bg unknown
- 2003-05-21 NO NO20032303A patent/NO332937B1/no not_active IP Right Cessation
- 2003-05-21 HR HR20030410A patent/HRP20030410B1/xx not_active IP Right Cessation
-
2004
- 2004-05-28 HK HK04103845A patent/HK1060848A1/xx not_active IP Right Cessation
- 2004-05-28 US US10/855,703 patent/US7351723B2/en not_active Expired - Lifetime
-
2008
- 2008-01-22 US US12/010,124 patent/US8754108B2/en not_active Expired - Lifetime
- 2008-02-28 CY CY20081100226T patent/CY1107896T1/el unknown
-
2013
- 2013-08-21 AR ARP130102967A patent/AR092374A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034277A1 (es) | Proceso para la produccion de una preparacion liofilizada de pantoprazol, preparacion liofilizada de pantoprazol obtenida, inyeccion de pantoprazol obtenida por reconstitucion en un disolvente y kit de inyeccion | |
| ATE526022T1 (de) | Stabilisierte zusammenstellungen die benzimidazole enthalten | |
| ES2026182T3 (es) | Un proceso para la produccion de un solido granular adecuado para su utilizacion como polvo detergente o un compuesto del mismo. | |
| AU6266101A (en) | A cleansing device for wc pans | |
| BRPI0413967A (pt) | polìmero solúvel em água, processo para preparar um polìmero solúvel em água, composição e solução aquosa | |
| ATE400603T1 (de) | Polybiphenylenethersulfone mit reduzierter verfärbung und verfaheren zu ihrer herstellung | |
| ES2111083T3 (es) | Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno). | |
| TW354388B (en) | Novel sulfonium salt and chemically amplified positive resist composition | |
| AR009604A1 (es) | Procedimiento para la separacion de clna de una solucion de cili | |
| ATE68185T1 (de) | Verfahren zur herstellung von 2,5-dimethylbzw. 2,5-diethyl-1,4;3,6-dianhydrosorbitol. | |
| WO2003101452A8 (en) | Process for the preparation of highly pure rabeprazole sodium salt | |
| ES2023854B3 (es) | Medio de tratamiento de cabello. | |
| AR032535A1 (es) | Metodo de fabricar bolsas que tienen tiras de cierre complementarias, una maquina de fabricacion, y bolsas obtenidas mediante ellos | |
| BRPI0416637A (pt) | método para produção de uma solução aquosa de etanolamina de cobre e de uma solução de monoetanolamina de cobre | |
| CO5640096A2 (es) | Formulaciones inodoras para tratar las discontinuidades mucosales | |
| ATE317259T1 (de) | Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat | |
| BR0104738A (pt) | Beta-hidroxialquilamidas, processo para sua produção e seu uso | |
| ATE345369T1 (de) | Verfahren zur herstellung einer flüssigformulierung von salzen sulfonsaurer azofarbstoffe | |
| PT1272495E (pt) | Processo para a preparacao de cefoperazona de sodio altamente cristalina | |
| AR027687A1 (es) | Procedimiento para preparar camptotecina | |
| BR0317957A (pt) | Processo para fabricar um b-hidroxinitrilo solúvel em água | |
| FR2816954B1 (fr) | Solution aqueuse boree, realiser a partir d'un compose d'acide borique et de carbonate de sodium | |
| CO5160306A1 (es) | N-metil-o-fenilenodiamina y su proceso de obtencion | |
| DK0481253T3 (da) | Nye p-oxybenzoesyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| AR028729A1 (es) | Nuevo procedimiento para la preparacion de pirazolopirimidinonas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |